LeadIQ logo
Learn more at LeadIQ.com

Insights

Loading spinner
Gathering insights about Jecure Therapeutics…

Jecure Therapeutics Tech Stack

Jecure Therapeutics uses 8 technology products and services including RSS, Open Graph, MySQL, and more. Explore Jecure Therapeutics's tech stack below.

  • RSS
    Content Management System
  • Open Graph
    Content Management System
  • MySQL
    Database
  • Font Awesome
    Font Scripts
  • jQuery Migrate
    Javascript Libraries
  • Underscore.js
    Javascript Libraries
  • RankMath SEO
    Web Platform Extensions
  • Nginx
    Web Servers

Jecure Therapeutics's Email Address Formats

Jecure Therapeutics uses at least 1 format(s):
Jecure Therapeutics Email FormatsExamplePercentage

Frequently Asked Questions

What is Jecure Therapeutics's phone number?

Minus sign iconPlus sign icon You can contact Jecure Therapeutics's main corporate office by phone at
+1-619-541-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Jecure Therapeutics's official website and social media links?

Minus sign iconPlus sign iconJecure Therapeutics's official website is jecuretx.com and has social profiles on LinkedInCrunchbase.

What is Jecure Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign iconJecure Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Jecure Therapeutics have currently?

Minus sign iconPlus sign iconAs of December 2025, Jecure Therapeutics has approximately 11 employees across 1 continents, including North America. Key team members include Scientist: L. T.. Explore Jecure Therapeutics's employee directory with LeadIQ.

What industry does Jecure Therapeutics belong to?

Minus sign iconPlus sign iconJecure Therapeutics operates in the Biotechnology Research industry.

What technology does Jecure Therapeutics use?

Minus sign iconPlus sign iconJecure Therapeutics's tech stack includes RSSOpen GraphMySQLFont AwesomejQuery MigrateUnderscore.jsRankMath SEONginx.

When was Jecure Therapeutics founded?

Minus sign iconPlus sign iconJecure Therapeutics was founded in 2016.

Jecure Therapeutics

Biotechnology ResearchCalifornia, United States11-50 Employees

Jecure Therapeutics is focused on the discovery of innovative therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) and liver fibrosis. Jecure’s academic founder is Dr. Ariel Feldstein, Division Chief of Gastroenterology at UCSD School of Medicine and a leading physician-scientist in hepatology. With operations in the biotech hub of San Diego, California, Jecure combines emerging NASH biology from Dr. Feldstein’s lab with an elite discovery team of veteran pharma/biotech scientists. Jecure’s lead program has identified small molecule inhibitors of a novel target and pro-inflammatory driver of NASH. Jecure is backed by top-tier life science investor Versant Ventures.

Section iconCompany Overview

Phone number
+1-619-541-****
Website
jecuretx.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $1M

    Jecure Therapeutics's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $1M

    Jecure Therapeutics's revenue is estimated to be in the range of $1M

Company Leadership

  • Stylized image of a person
    L. T.
    Scientist
    Phone icon
    Mobile Phone

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.